VAP-1: an adhesin and an enzyme.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMID 11274927)

Published in Trends Immunol on April 01, 2001

Authors

M Salmi1, S Jalkanen

Author Affiliations

1: MediCity Research Laboratory, Tykistökatu 6A, University of Turku, FIN-20520 Turku, Finland. marko.salmi@utu.fi

Articles citing this

Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest (2005) 2.75

A metagenomic study of diet-dependent interaction between gut microbiota and host in infants reveals differences in immune response. Genome Biol (2012) 1.62

Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening. Infect Immun (2002) 1.26

Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. Am J Pathol (2005) 1.13

Nuclear imaging of inflammation: homing-associated molecules as targets. EJNMMI Res (2013) 1.04

PET imaging of inflammation biomarkers. Theranostics (2013) 1.04

The origin of mammalian plasma amine oxidases. J Neural Transm (Vienna) (2007) 1.00

Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes. Am J Pathol (2002) 0.96

Structure and inhibition of human diamine oxidase. Biochemistry (2009) 0.95

PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG. Eur J Nucl Med Mol Imaging (2010) 0.92

Gallium-labelled peptides for imaging of inflammation. Eur J Nucl Med Mol Imaging (2012) 0.91

(68)Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones. Eur J Nucl Med Mol Imaging (2007) 0.89

Mini-PEG spacering of VAP-1-targeting 68Ga-DOTAVAP-P1 peptide improves PET imaging of inflammation. EJNMMI Res (2011) 0.87

Reversible inhibition of copper amine oxidase activity by channel-blocking ruthenium(II) and rhenium(I) molecular wires. Proc Natl Acad Sci U S A (2005) 0.86

Cellular localization and trafficking of vascular adhesion protein-1 as revealed by an N-terminal GFP fusion protein. J Neural Transm (Vienna) (2013) 0.84

Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation. Am J Pathol (2006) 0.84

Crystallization of a truncated soluble human semicarbazide-sensitive amine oxidase. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.84

Crossing the Vascular Wall: Common and Unique Mechanisms Exploited by Different Leukocyte Subsets during Extravasation. Mediators Inflamm (2015) 0.82

A new crystal form of human vascular adhesion protein 1. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.81

Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis. J Neural Transm (Vienna) (2007) 0.81

The role of protein crystallography in defining the mechanisms of biogenesis and catalysis in copper amine oxidase. Int J Mol Sci (2012) 0.80

(68)Ga-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and staphylococcal infections. EJNMMI Res (2014) 0.79

Tyrosine 381 in E. coli copper amine oxidase influences substrate specificity. J Neural Transm (Vienna) (2011) 0.79

68Ga-DOTA-Siglec-9--a new imaging tool to detect synovitis. Arthritis Res Ther (2015) 0.79

Structural organization of mammalian copper-containing amine oxidase genes. Inflamm Res (2010) 0.78

Novel pyridazinone inhibitors for vascular adhesion protein-1 (VAP-1): old target-new inhibition mode. J Med Chem (2013) 0.78

Post-ischemic vascular adhesion protein-1 inhibition provides neuroprotection in a rat temporary middle cerebral artery occlusion model. J Neurochem (2012) 0.77

Functional modulation of vascular adhesion protein-1 by a novel splice variant. PLoS One (2013) 0.76

Blockade of vascular adhesion protein-1 attenuates choroidal neovascularization. Mol Vis (2012) 0.76

Adhesion molecules in CNS disorders: biomarker and therapeutic targets. CNS Neurol Disord Drug Targets (2013) 0.75

Leukocyte trafficking-associated vascular adhesion protein 1 is expressed and functionally active in atherosclerotic plaques. Sci Rep (2016) 0.75

Articles by these authors

(truncated to the top 100)

Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol (1987) 3.84

Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med (1989) 3.68

Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet (1990) 3.55

A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science (1986) 2.91

Homing receptors and the control of lymphocyte migration. Immunol Rev (1986) 2.26

A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science (1992) 2.06

Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.80

Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear. Circ Res (2000) 1.61

Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med (1998) 1.61

Induction and function of vascular adhesion protein-1 at sites of inflammation. J Exp Med (1993) 1.58

Evolutionary conservation of tissue-specific lymphocyte-endothelial cell recognition mechanisms involved in lymphocyte homing. J Cell Biol (1988) 1.51

Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms. J Exp Med (1995) 1.48

Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells. J Cell Biol (1997) 1.46

How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv Immunol (1997) 1.43

CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73. J Exp Med (1995) 1.37

Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel diseases. Gastroenterology (1994) 1.37

Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol (1993) 1.35

Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol (1993) 1.34

A cell surface amine oxidase directly controls lymphocyte migration. Immunity (2001) 1.24

Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior. Diabetes (1996) 1.23

Immune cell trafficking in uterus and early life is dominated by the mucosal addressin MAdCAM-1 in humans. Gastroenterology (2001) 1.22

Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol (1998) 1.20

Ly-6C regulates endothelial adhesion and homing of CD8(+) T cells by activating integrin-dependent adhesion pathways. Proc Natl Acad Sci U S A (1997) 1.20

CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism. J Immunol (2000) 1.19

Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology (1996) 1.19

Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes. J Exp Med (1997) 1.18

Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. J Exp Med (2001) 1.17

Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells. J Exp Med (1996) 1.17

Mucosal addressin is required for the development of diabetes in nonobese diabetic mice. J Immunol (1998) 1.13

Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions. FASEB J (2001) 1.13

Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J Rheumatol (1992) 1.11

Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules. J Immunol (2001) 1.05

Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans. J Am Coll Cardiol (2000) 1.05

Human lymphocyte and lymphoma homing receptors. Annu Rev Med (1987) 1.05

Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology (2000) 1.04

Human vascular adhesion protein-1 in smooth muscle cells. Am J Pathol (1999) 1.04

Molecules controlling lymphocyte migration to the gut. Gut (1999) 1.04

Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion. J Clin Invest (1997) 1.04

Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology (1996) 1.03

In vivo detection of vascular adhesion protein-1 in experimental inflammation. Am J Pathol (2000) 1.03

Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium. J Immunol (1993) 1.02

Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models. Eur J Immunol (1995) 1.02

Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo. FASEB J (2001) 1.00

YadA mediates specific binding of enteropathogenic Yersinia enterocolitica to human intestinal submucosa. Infect Immun (1994) 0.98

Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1). Eur J Immunol (1996) 0.98

CD73 mediates adhesion of B cells to follicular dendritic cells. Blood (1996) 0.97

Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity. J Immunol (1998) 0.96

Cell adhesion and migration. IV. Lymphocyte trafficking in the intestine and liver. Am J Physiol (1998) 0.95

Selective endothelial binding of interleukin-2-dependent human T-cell lines derived from different tissues. Proc Natl Acad Sci U S A (1992) 0.95

Yersinia lipopolysaccharide is modified by human monocytes. Infect Immun (1993) 0.94

Regulation of lymphocyte traffic to mucosa-associated lymphatic tissues. Gastroenterol Clin North Am (1991) 0.94

Immunological detection of proteins after isoelectric focusing in thin layer agarose gel: a specific application for the characterization of immunoglobulin diversity. J Clin Lab Immunol (1983) 0.94

Flow cytometric analysis of the Hermes homing-associated antigen on human lymphocyte subsets. Blood (1989) 0.93

Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy. Leukemia (2012) 0.93

Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes. Infect Immun (1997) 0.92

Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma. Br J Cancer (1993) 0.92

Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of IBD. Inflamm Bowel Dis (1998) 0.92

Structural model of the catalytic domain of an enzyme with cell adhesion activity: human vascular adhesion protein-1 (HVAP-1) D4 domain is an amine oxidase. Protein Eng (1998) 0.92

Mouse vascular adhesion protein 1 is a sialoglycoprotein with enzymatic activity and is induced in diabetic insulitis. Am J Pathol (1999) 0.91

Serum CD44 in malignant lymphoma: an association with treatment response. Blood (1994) 0.90

Elevated serum CD44 level is associated with unfavorable outcome in non-Hodgkin's lymphoma. Blood (1997) 0.89

Defect in the generation of light-chain diversity in bursectomized chickens. Nature (1984) 0.89

Increased synovial endothelium binding and transendothelial migration of mononuclear cells during Salmonella infection. Arthritis Rheum (1998) 0.89

Endothelial cell-binding properties of lymphocytes infiltrated into human diabetic pancreas. Implications for pathogenesis of IDDM. Diabetes (1993) 0.88

Low or undetectable numbers of Philadelphia chromosome-positive leukemic stem cells (Ph(+)CD34(+)CD38(neg)) in chronic myeloid leukemia patients in complete cytogenetic remission after tyrosine kinase inhibitor therapy. Leukemia (2009) 0.88

CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis. J Pathol (1995) 0.88

Organ-selective regulation of vascular adhesion protein-1 expression in man. Eur J Immunol (1997) 0.88

Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study. Cancer (1990) 0.86

The role of two distinct endothelial molecules, vascular adhesion protein-1 and peripheral lymph node addressin, in the binding of lymphocyte subsets to human lymph nodes. J Immunol (1998) 0.86

Interactions between endothelial cells and leukocytes. J Cell Biochem (1986) 0.85

Recirculation and homing of lymphocyte subsets: dual homing specificity of beta 7-integrin(high)-lymphocytes in nonobese diabetic mice. Blood (1996) 0.85

Origin and function of circulating CD44 in non-Hodgkin's lymphoma. J Immunol (1997) 0.85

Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells. Cancer Res (1997) 0.84

Vascular adhesion protein 1 mediates binding of immunotherapeutic effector cells to tumor endothelium. J Immunol (2001) 0.84

Induction of vascular adhesion protein-1 during liver allograft rejection and concomitant cytomegalovirus infection in rats. Am J Pathol (2000) 0.83

CD73 mediates lymphocyte binding to vascular endothelium in inflamed human skin. Eur J Immunol (1997) 0.83

Intracellular pathogens and professional phagocytes in reactive arthritis. Pathobiology (1991) 0.82

Clinical significance of circulating CD44 in non-Hodgkin's lymphoma. Int J Cancer (1998) 0.82

A mouse molecular mimic of human vascular adhesion protein-1. Mol Immunol (1998) 0.82

Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma. Cancer (1991) 0.82

Expression of alpha4-integrins on human neutrophils. J Leukoc Biol (2000) 0.81

Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma. J Clin Oncol (1994) 0.81

Vascular adhesion protein-1 in human ischaemic stroke. Neuropathol Appl Neurobiol (2007) 0.81

The gene for human lymphocyte homing receptor is located on chromosome 11. Eur J Immunol (1989) 0.81

Function of lymphocyte homing-associated adhesion molecules on human natural killer and lymphokine-activated killer cells. J Immunol (1997) 0.81

Nurse cells of the bursa of Fabricius: do they exist? Eur J Immunol (1990) 0.80

Immune capacity of the chicken bursectomized at 60 hours of incubation: mitogen-induced cell proliferation and immunoglobulin secretion. J Immunol (1983) 0.80

Bursectomy of chicken embryos at 60 hours of incubation leads to an oligoclonal B cell compartment and restricted Ig diversity. J Immunol (1990) 0.80

Monocytes that have ingested Yersinia enterocolitica serotype O:3 acquire enhanced capacity to bind to nonstimulated vascular endothelial cells via P-selectin. Infect Immun (1999) 0.80

Semicarbazide-sensitive amine oxidase substrates fail to induce insulin-like effects in fat cells from AOC3 knockout mice. J Neural Transm (Vienna) (2007) 0.79

Immune capacity of the chicken bursectomized at 60 hours of incubation: failure to produce immune, natural, and autoantibodies in spite of immunoglobulin production. Cell Immunol (1983) 0.78

Isolation, structural characterization, and chromosomal mapping of the mouse vascular adhesion protein-1 gene and promoter. J Immunol (1998) 0.78

Tumor endothelium selectively supports binding of IL-2-propagated tumor-infiltrating lymphocytes. J Immunol (1995) 0.78

Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma. Br J Cancer (1992) 0.78

Immune capacity of the chicken bursectomized at 60 hr of incubation: surface immunoglobulin and B-L (La-like) antigen-bearing cells. J Immunol (1983) 0.78

Expression of MHC class II molecules on human monocytes is regulated independently from each other after phagocytosis of bacteria. Scand J Immunol (1996) 0.77

Does soluble CD44 reflect the clinical behavior of human cancer? Curr Top Microbiol Immunol (1996) 0.77

Sialyl LewisX carbohydrate is expressed differentially during avian lymphoid cell development. Eur J Immunol (1995) 0.77

Regulation of L-selectin expression on cultured bone marrow leukocytes and their precursors. Eur J Immunol (1992) 0.77

Involvement of the avian mu heavy chain in recolonization of the bursa of Fabricius. Scand J Immunol (1992) 0.77